M06.29
Rheumatoid bursitis, multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Rheumatoid bursitis is a condition characterized by inflammation of the bursae—small, fluid-filled sacs that cushion and reduce friction between tissues of the body. When rheumatoid arthritis affects multiple bursae, the condition is classified as rheumatoid bursitis, multiple sites (ICD-10 Code M06.29). This disorder often accompanies other symptoms of rheumatoid arthritis and can cause significant discomfort and mobility issues. Recognizing the symptoms and understanding the underlying causes are crucial in managing the condition effectively.
Causes & Symptoms
Clinical Causes: Rheumatoid arthritis: An autoimmune disorder where the immune system mistakenly attacks joint tissues and bursae. Repeated trauma or overuse of joints: Can exacerbate existing inflammation. Infections of the bursae, although less common, can also trigger inflammation. Other inflammatory conditions that predispose bursae to inflammation.
Key Symptoms: Persistent pain around affected joints Swelling and warmth over the bursae Tenderness when touching the affected area Limited range of motion due to discomfort and swelling Redness of the skin overlying the bursae General symptoms associated with rheumatoid arthritis, such as fatigue and malaise Multiple affected sites may result in widespread discomfort across joints
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough medical history and physical examination focusing on affected joints and bursae. Imaging studies such as ultrasound or MRI can identify bursitis and assess the extent of inflammation. Blood tests may be performed to detect markers of inflammation and rheumatoid arthritis, including rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies. Sometimes, aspiration of joint fluid is performed to rule out infections or other causes.
Treatment Protocols: Management of rheumatoid bursitis aims to reduce inflammation, relieve symptoms, and prevent joint damage. Common approaches include: - **Medications:** Nonsteroidal anti-inflammatory drugs (NSAIDs) to alleviate pain and inflammation; corticosteroid injections directly into the bursae for more severe inflammation; disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis. - **Physical therapy:** Exercises to maintain joint mobility and strengthen surrounding muscles. - **Rest and activity modification:** Avoiding activities that worsen symptoms. - **Ice application:** To reduce swelling and inflammation. - **Surgical intervention:** In rare cases, bursae may be aspirated or surgically removed if conservative treatments are ineffective. It is essential for individuals diagnosed with rheumatoid bursitis to work closely with healthcare providers to tailor a management plan suited to their specific needs.
Clinical Advice & FAQs
Billing Guidance
Is M06.29 a billable ICD-10 code?
Yes, M06.29 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M06.29?
Clinical documentation must specify the nature of Rheumatoid bursitis, multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference